マクロファージの移動阻害因子の発現は,ヒト動脈硬化症の異なる段階において
Anke Burger-Kentischer1, Heike Goebel, Rüdiger Seiler
1Laboratory of Biochemistry, Institute for Interfacial Engineering, University of Stuttgart, Stuttgart, Germany.
Circulation
|April 3, 2002
まとめ
マクロファージの移動阻害因子 (MIF) は,動脈硬化で上調され,すべての病変細胞に存在し,Jab1と相互作用します. 酸化されたLDLは,内皮細胞におけるMIF発現を増加させ,プラーク発達の役割を示唆している.
科学分野:
- 心血管生物学 心血管生物学
- 免疫学 免疫学とは
- 病理学 パトロジー
背景:
- 動脈硬化症は慢性炎症性動脈疾患である.
- マクロファージ移動阻害因子 (MIF) は,疾患進行に関与する重要な炎症性サイトカインです.
研究 の 目的:
- 人間の動脈硬化病変におけるMIFとJab1の発現を調査する.
- 初期アテロゲネシスにおけるMIFの役割と,酸化LDLによるMIFの調節を決定する.
主な方法:
- MIFとJab1を分析するための免疫ヒスト化学と共免疫プレシピテーション.
- 培養ヒト血管内皮細胞とマクロファージにおけるMIF発現を研究した.
主要な成果:
- MIFとJab1は,動脈硬化性病変内のすべての細胞タイプに存在します.
- MIFの発現は動脈硬化症の進行とともに増加し,局所的に生成されます.
- MIFとJab1は,体内で複合体を形成し,酸化されたLDLは,内皮細胞におけるMIFを上調する.
結論:
- MIFは,すべての動脈硬化性病変に豊富に存在し,早期のプラーク発症と進行した疾患を引き起こす可能性があります.
- MIF-Jab1複合体は,動脈硬化病変の進化を調節する可能性があります.
関連する概念動画
Pathophysiology of Heart Failure
4.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Imbalances in Cardiac Output
3.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Myocarditis I: Introduction
645
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
645
Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Heart Failure II: Pathophysiology
1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Hypertension II: Pathophysiology
1.8K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K


